The structure of the leading causes of death in Serbia has considerably changed in the last half century. Diseases which presented the main threat to the population a few decades ago are now at the level of a statistical error. On the one side are causes which drastically changed their share in total mortality in this time interval, while others have shown stability and persistence among the basic causes of death. Acute infectious diseases "have been replaced" with chronic noninfectious diseases, due to the improvement of general and health conditions. One of the consequences of such changes is increased life expectancy and a larger share of older population which resulted in cardiovascular diseases and tumors to dominate more and more in total mortality. Convergent trends in the structure of the leading causes of death in Serbia from the middle of the 20th century are the reasons why there are considerably fewer diseases and causes with a significant rate in total population mortality at the beginning of the 21st century. During the 1950s, there were five groups of diseases and causes which participated individually with more than 10% of population mortality (infectious diseases, heart and circulatory diseases, respiratory diseases, some perinatal conditions and undefined states) while at the beginning of the new century there were only two such groups (cardiovascular diseases and tumors). Identical trends exist in all European countries, as well as in the rest of the developed world. The leading causes of death in Serbia are cardiovascular diseases. An average of somewhat over 57.000 people died annually in the period from 2007 - 2009, which represents 55.5% of total population mortality. Women are more numerous among the deceased and this difference is increasing due to population feminization. The most frequent cause of death in Serbia, after heart and circulatory diseases, are tumors, which caused 21,415 deaths in 2009. Neoplasms are responsible for one fifth of all deaths. Their number has doubled in three decades, from 9,107 in 1975 to about 20,000 at the beginning of the 21st century, whereby tumors have become the fastest growing cause of death. Least changes in absolute number of deaths in the last half century were marked among violent deaths. Observed by gender, men are in average three times more numerous among violent deaths than women. In the middle of the 20th century in Serbia, one third of the deaths caused by violence were younger than 25 and as many as one half were younger than 35 years old. Only one tenth (11%) of total number of violent deaths were from the age group of 65 or older. At the end of the first decade of the 21st century (2009), the share of population younger than 25 in the total number of violent deaths was decreased four times (and amounted to 8%). At the same time, the rate of those older than 65 or more quadrupled (amounted to 39%)
The 2020 pandemic came at a huge demographic cost, particularly regarding the increase in mortality. In this paper we examine excess deaths in Serbia and 34 other European countries in 2020. Methodological inconsistencies and big differences in how COVID-19 deaths were recorded across different countries make it difficult to make any cross-country comparisons, even with the scope limited only to Europe. Since the number of total deaths is a methodologically solid indicator, we looked at the differences between the total number of deaths in 2020 and compared that to deaths in 2019. The lowest increase in mortality - below 5% - occurred in countries in the north of Europe (Norway, Denmark, Finland, Latvia), while the highest increase - over 18% - was recorded in the southern and central parts of the continent (Albania, Northern Macedonia, Spain, Belgium, Poland, Slovenia, Russia). There is no clear geographical regularity. In 2020, Serbia had 12.6% more deaths compared to 2019, which was close to the European average. Within Serbia, statistical differences between regions were not large. Measuring the contribution of COVID-19 deaths to excess mortality is much more problematic. The excess death ratio is more helpful for understanding methodological and data-gathering issues than finding evidence about composition and divergence in mortality. According to this indicator (based on preliminary data), only 25% of excess deaths in Serbia in 2020 were caused by COVID-19, while the European average was 54%. However, in many (primarily Eastern European) countries in 2020, the indirect consequences of COVID-19 on the health of the population were more significant than the direct ones. It is precisely the ratio of COVID-19 diagnoses that led to death in total mortality that shows this. The final results may confirm this statement or indicate potential data manipulation. While this paper focuses only on the year 2020, as of Q1 of 2021, the pandemic is not nearing its end. Based on preliminary data published daily, Serbia had more COVID-19 deaths in the first four months of 2021 than for the whole of 2020. This indicates that the consequences of the pandemic for Serbia will be dire in 2021, regardless of the course the pandemic takes.
The research presented in this paper is dealing with mortality and its impact on the natural increase, i.e. population dynamics in Serbia at the beginning of the 21st century. The aim is to draw attention to the potential of mortality as a natural component of changes in population when it comes to the possibility of mitigating the negative population trends. This paper will analyse changes in the age patterns of mortality of Serbian population from the mid 20th century, in order to point to the lack of progress in reducing age-specific mortality. The comparison with countries with low mortality rates (Slovenia and Sweden) will highlight the potential space for further mortality reduction in Serbia. The effect of a hypothetical fall of mortality by age on the level of natural increase will be measured on the basis of population projections for the period of half a century.
This paper analyses the differential mortality in Vojvodina according to the economic activity and occupations of the population. The analysis covers the period from 1971 to 2011. The aim of the research is to determine the influence of socioeconomic factors on differences in the level of mortality among different population groups. In particular, the aim is to detect the impact of working conditions and manner of performing the job to the differences in the mortality of the population with different occupations. Also, the goal is to detect changes in differential mortality according to economic activity and occupations of the population during the analysed period.
The use of tobacco in Serbia has for many years been one of the most frequent risk factors affecting disease development. Although its impact is often neglected and the effects on health minimised, reviewing the existing literature and calculating the tobacco consumption impact on the mortality of the population in Serbia (using the Peto-Lopez method) show a clear link between smoking and health of the population. Serbian population is heavily burdened with the negative effects of tobacco on health, especially men. At the beginning of the second decade of the 21st century, mortality from the illness or cause of death associated with smoking was at about 17% of the total mortality. In men, it is estimated that even a quarter of the total mortality is associated with smoking. In the female population, the share of smokers is considerably lower, and consequently the mortality from this factor is lower, about 9% of the total mortality. Of all major disease groups, tumours are most affected by smoking. The share of tobaccorelated mortality in neoplasms is high and accounts for 30% (43% in men and 14% in women). In cardiovascular diseases, the impact of smoking is much smaller and about 6,000 deaths per year are associated with the use of tobacco. Since the early 1990s, the number of smoking-attributable death has been growing. Relatively, the share of men has not changed, but for 20 years of analysis the share of women has significantly increased from 5% to 9%. In all age groups, the share of smoking-related mortality has increased in the female population, especially in the 45-69 age range where mortality has been doubled. Surveys on the health of the Serbian population also confirm the trend of increasing the share of women smokers in the population, especially in the categories of young people. Men in Serbia (35-69 years of age) have the highest smoking-attributable death rate in Europe. As much as 44% of total deaths in that age are directly related to smoking. Besides Hungary, where mortality in men is also relatively high (42%), other countries have significantly lower shares. Observed at the level of the entire continent, countries of the Balkan Peninsula (and their neighbours) have the highest shares of smoking-attributable death. Women in Serbia have a moderately high share of 9% and are among the ten most vulnerable countries in Europe. The biggest difference in smoking-related mortality by gender is observed in the Pyrenees Peninsula and in the eastern and south-eastern parts of Europe. These are also the countries with the largest absolute difference in the mortality rate of men and women, thus confirming the hypothesis that tobacco smoke, as a single mortality factor, plays the most important role in establishing a different gender mortality pattern. A high percentage of smokers in the total population limits the growth of life expectancy and affects the difference in gender mortality rate. If a certain mortality factor potentially affects the life expectancy of up to three years for men in Serbia, as shown in the paper, then it is especially important to pay attention to measures of prevention and awareness of the population regarding this issue. Moreover, it is particularly important to recognise the consequences of passive smoking the youth and children are exposed to, since in Serbia there is a great deal of tolerance for smoking indoors. [Project of the Serbian Ministry of Education, Science and Technological Development, Grant no. III47006]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.